Second Allogeneic Stem Cell Transplantation for Acute Leukemia Using a Chemotherapy-Only Cytoreduction with Clofarabine, Melphalan, and Thiotepa.

Item

http://www.wikidata.org/entity/Q40752008

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Second Allogeneic Stem Cell Tr ...... bine, Melphalan, and Thiotepa.

@en

type

Item

label

Second Allogeneic Stem Cell Tr ...... bine, Melphalan, and Thiotepa.

@en

prefLabel

Second Allogeneic Stem Cell Tr ...... bine, Melphalan, and Thiotepa.

@en

P1476

Second Allogeneic Stem Cell Tr ...... bine, Melphalan, and Thiotepa.

@en

P2093

Andromachi Scaradavou

http://www.w3.org/2001/XMLSchema#string

Barbara Spitzer

http://www.w3.org/2001/XMLSchema#string

Emily C Zabor

http://www.w3.org/2001/XMLSchema#string

Esperanza B Papadopoulos

http://www.w3.org/2001/XMLSchema#string

Farid Boulad

http://www.w3.org/2001/XMLSchema#string

Hugo Castro-Malaspina

http://www.w3.org/2001/XMLSchema#string

James W Young

http://www.w3.org/2001/XMLSchema#string

Miguel-Angel Perales

http://www.w3.org/2001/XMLSchema#string

Nancy A Kernan

http://www.w3.org/2001/XMLSchema#string

Nicholas Webb

http://www.w3.org/2001/XMLSchema#string

P2860

Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults

Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change.

Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials.

Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission.

AAML0523: a report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia.

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromes.

Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a center for international blood and marrow transplant research study.

Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts.

Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell t

P304

1449-1454

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2016.05.001

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27184623

http://www.w3.org/2001/XMLSchema#string

P932

4989237

http://www.w3.org/2001/XMLSchema#string